Posts Tagged ‘Nigeria’

How a Nigerian General Became an Advocate for Stopping River Blindness

October 31st, 2012

Lieutenant General (Ret.) Theophilus Yakubu (TY) Danjuma knows river blindness firsthand. As a Nigerian who grew up in a country with one of the highest rates of river blindness (also known as onchocerciasis) infection in the world, he has not only witnessed the devastation this disease can bring to families and communities, but has also suffered from the disease himself.

River blindness produces rashes, skin lesions and severe skin inflammation that can make the skin change color and lose elasticity. People suffering from the disease often face daily social humiliation and isolation, and infected children struggle to pay attention in school because of intense itching. River blindness, however, is aptly named. Its most debilitating symptoms are severe visual impairment and irreversible blindness.

General Danjuma’s experience with this disease began in the 1960s. While leading a company of soldiers in Nigeria, he was bitten by the Simulium black fly that transmits the worm larvae that cause river blindness. For two years, the larvae spread throughout his body, maturing into adult worms and releasing bacteria that eventually trigger an immune system response. He awoke one morning with swollen eyes and itchy, inflamed skin. General Danjuma successfully underwent two weeks of treatment and experienced no lasting symptoms, but says he has never forgotten the sight of his own skin sample under the microscope at the local clinic. He still shivers at the memory of tiny worms swimming in and out of view under the lens.

General Danjuma is the Grand Patron of an important NGO based in Jos, in Northern Nigeria. The NGO, The Mission to Save the Helpless, better known by its acronym MITOSATH” is well known to the health team in the Africa Region as an important partner of African Programme for Onchocerciasis Control (APOC). MITOSATH is also among the most active NGOs in Nigeria contributing to the control of river blindness other neglected tropical diseases.

Controlling River Blindness in Africa: Setting an Example

A young boy leads a man impacted by river blindness. Photo by Olivier Asselin.

 

 

 

 

 

 

 

 

 

 

 

 

 

When river blindness control programs were first implemented in the 1970s, up to half of all adults in some hard-hit communities had gone blind from the disease. This tragedy caused many Africans to abandon their ancestral homes and livelihoods; the economic losses were estimated at US$30 million. The first Onchocerciasis Control Programme focused primarily on spraying insecticide over infected areas in order to minimize the prevalence of the black fly, preventing transmission of the parasitic worms from person to person, and eventually incorporated treatment with Ivermectin, the drug that treats river blindness, when it became available.

With the help of the World Health Organization and the World Bank in 1995, this program was expanded and renamed the African Programme for Onchocerciasis Control (APOC). Rather than attempting to control the black fly population, APOC sought to control the parasitic worms in humans through community-directed treatment with Ivermectin in 19 countries. Treatment with Ivermectin successfully kills the worms in the people who have them, thereby disrupting transmission of the disease.

Merck & Co. donates Ivermectin to Nigeria (and other countries in need), and APOC trains volunteers to distribute the drug in communities. Today, APOC provides Ivermectin to more than 96 percent of endemic communities in Nigeria, reaching more than 23 million people. Until everyone is treated, however, the risks of re-infection and new outbreaks remain. River blindness is still present in most Nigerian states, including Taraba state where General Danjuma was born. The disease continues to deeply impact communities and the lifetime productivity of the 31 million Nigerians at risk.

Now a successful businessman and politician, General Danjuma’s personal experience with river blindness and the success of MITOSATH and APOC motivated him to donate US$1 million to the program in 2010. With his donation, he hopes to invigorate interest in public health challenges in rural Africa. General Danjuma noted that, “these are not the neglected diseases of tropical Africa, but rather the diseases of neglected people.”

General Danjuma’s crusade to raise the profile of rural health issues has already gained momentum. Following his example, in 2011, the government of Nigeria pledged an additional US$5 million to APOC to assist with its control efforts. General Danjuma hopes that other countries and the private sector will join the movement to eliminate this debilitating disease once and for all.

 

In March 2012, General Danjuma participated in a panel discussion at the Center for Strategic and International Studies. Read our blog post on that event here.

 

The Demise of Trachoma in Nigeria

March 23rd, 2011

International Trachoma Initiative (ITI) estimates that 53 million people are living in trachoma-endemic areas of Nigeria.

“After receiving its first donation of Zithromax®, to be taken orally,  from Pfizer for trachoma control, Nigeria distributed 1,100,197 doses through mass drug administration (MDA) in ten districts in five states. ”

"The gray areas on the map show the districts within five trachoma-endemic Nigerian states where residents received Zithromax® to treat and prevent blinding trachoma."

Benjamin Nwobi, the National Coordinator for Nigeria’s National Program for the Prevention of Blindness, an initiative under the Federal Ministry of Health, stated that “the Northern geo-political zones of Nigeria fall within the WHO-classified ‘Trachoma Belt’ where trachoma contributes significantly to this avoidable blindness.”

Nwobi confirms that:

the Nigerian Federal Ministry of Health plans to expand distribution to 22 districts in seven states in 2011 in collaboration with its in-country partners CBM (formerly Christoffel Blindenmission), The Carter Center, and Sightsavers. Under the leadership of the National Program, ITI hopes to gradually help scale-up the Zithromax® donation to all trachoma-endemic states of Nigeria that are prepared to implement the full SAFE strategy.

To combat trachoma, World Health Organization (WHO) has deployed an integrative strategy called SAFE.  All components of this strategy must be complete in order to successfully complete a trachoma control program.

Surgery for people at immediate risk of blindness
Antibiotic therapy to treat individual active cases
and reduce the community reservoir of infection
Facial cleanliness and improved hygiene to
reduce transmission
Environmental improvements to make living
conditions better so that the environment
no longer facilitates the maintenance and
transmission of trachoma

In 2010, Mass Drug Administration (MDA) of Zithromax® reached five Nigerian  trachoma-endemic states: “Nassarawa and Plateau in the central region, and Sokoto, Kebbi, and Zamfara in northern Nigeria.”

Trachoma is the world’s leading cause of preventable blindness. It is a communicable infectious disease caused by chlamydia trachomatis bacterium.  Symptoms of infections are not immediately visible and people who are infected are not immediately blind.  It is often transmitted in childhood, and it is when one reaches adulthood do severe symptoms appear.  Trachoma tends to breed in areas with poor access to clean water and sanitation and Africa is reported to be the most affected continent though Latin America, Middle East, Asia and Western Pacific all have several reported endemic cases.  ITI, in collaboration with several other organizations, designed the Trachoma Atlas which maps out trachoma-endemic regions of the world.

Trachoma is a common neglected tropical disease (NTD) and thankfully, collaborative efforts, like those demonstrated by ITI, have been working hard to give this preventable disease a resounding voice.

Read the original article here.

Success in the fight against NTDs in Zamfara, Nigeria

February 10th, 2011

By: Marthe Damina, Project Officer with Sightsavers

This week, my colleagues in the United Kingdom will present Sightsavers’ initial findings of a pilot neglected tropical diseases (NTD) project that I worked on in Nigeria, to the All Party Parliamentary Group on Malaria and NTDs. The pilot programme in Zamfara State is groundbreaking for Sightsavers and for the area.

Groundbreaking for us – as it’s the first time Sightsavers has invested in treating NTDs outside of the blinding onchocerciasis (oncho) and trachoma, which we’ve been supporting the control of in the area since 1996 and 2003 respectively.

Groundbreaking for Zamfara – because it’s the first time that state-wide NTD prevalence mapping has taken place in Nigeria. The mapping of three of the top five NTDs showed a prevalence range of 8.8% to 48.1% for schistosomiasis (schisto), 8.8% to 18.5% for soil transmitted helminths (STH) and 6% to 22% for lymphatic filariasis (LF). These diseases have serious implications for childhood growth, intellectual development, educational outcomes and productivity.

» Read more: Success in the fight against NTDs in Zamfara, Nigeria

Reading List 2/3/2011

February 3rd, 2011

Happy Thursday readers! Check out the first reading list of February! Today we’re reading about successful mass drug treatment for lymphatic filiariasis in Iloilo City, Philippines, a new drug introduced by a Nigerian pharmaceutical company to treat worms, and Ghanaian scientists working together to combat infectious diseases.

Mass drug treatment for filariasis in Iloilo at 86% coverage, Robert Herriman, The Examiner
Neimeth tackles worm with new pyrantrin, The Guardian Nigeria
Ghanaian microbiologists team up to fight infectious disease, Africa News